未登录

Y

Young-Joon Ko

Animal and Plant Quarantine Agency

H指数:23

被引数:1,462

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Intradermal Vaccination Induces Protective Immunity Against Foot-and-Mouth Disease While Mitigating Milk Yield Reduction in Ruminants

皮内疫苗接种可诱导抗口蹄疫的保护性免疫，同时缓解反刍动物奶产量下降

IF3.4

2026-08-130

OA

Evaluation of Antigen Productivity and Inactivation Kinetics of a Recombinant Foot-and-Mouth Disease SAT1 Vaccine Strain

重组口蹄疫SAT1疫苗株的抗原生产力和灭活动力学评价

IF3.5

2026-05-070

OAAI

Evaluation of an In-House Developed Foot-and-Mouth Disease Virus SAT 3 Vaccine Strain Based on Antigen Productivity and Inactivation Kinetics for Commercial Feasibility

基于抗原生产力和灭活动力学对一种内部开发的口蹄疫病毒SAT 3疫苗株进行商业可行性评估

IF3.4

2026-04-270

OA

Enhancing Capsid Stability of a Foot-and-Mouth Disease Virus Vaccine Strain Through VP1-Directed Chimeric Design While Preserving Antigenicity

通过VP1定向嵌合设计增强口蹄疫病毒疫苗株的衣壳稳定性同时保留抗原性

IF3.4

2026-04-220

OA

Characterization of a Virus Rescued from a Full-Length Infectious Clone Derived from the Type A Foot-and-Mouth Disease Virus Isolated in South Korea

源自韩国分离的A型口蹄疫病毒全长感染性克隆拯救病毒的表征

Viruses 2025, Vol. 17, Page 1561

IF3.5

2025-11-290

OAAI

Construction of a Full-Length Infectious Clone Derived from Type O Foot-And-Mouth Disease Virus Isolated in South Korea for Vaccine Development with High Antigen Productivity

从韩国分离的O型口蹄疫病毒构建高抗原产量疫苗开发的全长感染性克隆

Vaccines 2025, Vol. 13, Page 1195

IF3.4

2025-11-270

OAAI

Evaluation of Recombinant Foot-and-Mouth Disease SAT2 Vaccine Strain in Terms of Antigen Productivity, Virus Inactivation Kinetics, and Immunogenicity in Pigs for Domestic Antigen Bank

重组口蹄疫SAT2疫苗株在抗原产量、病毒灭活动力学及猪免疫原性方面的评价，用于国内抗原库。

Vaccines 2025, Vol. 13, Page 704

IF3.4

2025-08-230

PRE

Neutralizing Antibody Screening Using NanoBiT-Based Virus-like Particles of Foot-and-Mouth Disease Type Asia1 Enhances Biosafety and Sensitivity

IF3.5

2025-02-270

OAAI

Calcium Chloride as a Novel Stabilizer for Foot-and-Mouth Disease Virus and Its Application in the Vaccine Formulation

氯化钙作为新型口蹄疫病毒稳定剂及其在疫苗制剂中的应用

IF3.4

2024-03-290

OAAI

Determination of Optimal Antigen Yield and Virus Inactivation Conditions for the Production of the Candidate Foot-and-Mouth Disease Recombinant Vaccine Strain Asia1 Shamir-R in a Bioreactor

IF3.5

2024-03-162

OAAI

Calcium Chloride Treatment Enhances Antigen Production in Foot-and-Mouth Disease Vaccines for Serotypes SAT1 and SAT3

氯化钙处理可增强口蹄疫疫苗中血清型SAT1和SAT3的抗原产量

IF3.4

2024-02-230

OAAI

Evaluation of Foot-and-Mouth Disease (FMD) Virus Asia1 Genotype-V as an FMD Vaccine Candidate: Study on Vaccine Antigen Production Yield and Inactivation Kinetics

IF3.4

2024-02-122

OAAI

Dectin-1 signaling coordinates innate and adaptive immunity for potent host defense against viral infection

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-06-027

OAAI

Development of Monoclonal Antibody to Specifically Recognize VP0 but Not VP4 and VP2 of Foot-and-Mouth Disease Virus

IF3.3

2022-12-080

OAAI

Factors Involved in Removing the Non-Structural Protein of Foot-and-Mouth Disease Virus by Chloroform and Scale-Up Production of High-Purity Vaccine Antigens

通过氯仿去除口蹄疫病毒的非结构蛋白和扩大生产高纯度疫苗抗原的因素

IF3.4

2022-06-244

OAAI

Comparison of High-Performance Liquid Chromatography with Sucrose Density Gradient Ultracentrifugation for the Quantification of Foot-and-Mouth Disease Vaccine Antigens

IF3.4

2022-04-223

OAAI

Validation of Pretreatment Methods for the In-Process Quantification of Foot-and-Mouth Disease Vaccine Antigens

口蹄疫疫苗抗原过程中定量预处理方法的验证

IF3.4

2021-11-194

OAAI

Scale-Up Production of Type O and A Foot-and-Mouth Disease Bivalent Vaccine and Its Protective Efficacy in Pigs

IF3.4

2021-06-024

OAAI

Production of a Foot-and-Mouth Disease Vaccine Antigen Using Suspension-Adapted BHK-21 Cells in a Bioreactor

在生物反应器中使用适应悬浮的BHK-21细胞生产口蹄疫疫苗抗原

IF3.4

2021-05-1317

OAAI

Development of a Potent Stabilizer for Long-Term Storage of Foot-and-Mouth Disease Vaccine Antigens

开发用于长期储存口蹄疫疫苗抗原的有效稳定剂

IF3.4

2021-03-126

OAAI